Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older whose vital signs are stable, meaning body temperature between 36.0°C and 38.0°C, pulse between 50 and 120 beats per minute, breathing rate between 10 and 24 breaths per minute, and blood pressure of at least 90/60 mmHg.
- People who are willing to take part in the study and sign a consent form agreeing to participate.
- People whose hematocrit level (a measure of red blood cells in the blood) falls between 25% and 60%.
- People who have been diagnosed with chronic kidney disease (a long-term condition where the kidneys do not work as well as they should).
Who may not be able to join:
- People who are currently in an unstable phase of a serious heart or brain condition, such as a recent stroke, brain bleed, or acute coronary syndrome (a sudden, severe heart problem).
- People who are currently experiencing a severe, unstable diabetes-related complication, such as diabetic ketoacidosis or a hyperosmolar hyperglycemic coma (confirm with trial site if unsure whether this applies).
- People who are currently experiencing acute kidney injury (a sudden, short-term loss of kidney function).
- People who have already started kidney replacement therapy, such as dialysis or a kidney transplant.
- People who are pregnant or breastfeeding.
- People who are currently taking part in another clinical trial, or who have done so within the past six months.
- People who are unable to understand spoken or written instructions, including the information in the consent form.
- People who are unable to cooperate with the study's procedures.
- People whom the trial investigators consider unsuitable for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiujuan Zang, MD, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Phone: +8618918289268
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of Hyperkalemia.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.